A low MW inhibitor of CD44 dimerization for the treatment of glioblastoma

As a hallmark of glioblastoma multiforme (GBM), CD44 plays a crucial role in promoting glioblastoma stem cell (GSC) stemness phenotypes and multiple drug resistance. The therapeutic potential of CD44 has been validated by the clinical successes of several CD44 inhibitors, including antibodies and hyaluronan‐related drugs.

[1]  Christopher Southan,et al.  THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Enzymes , 2019, British journal of pharmacology.

[2]  P. Perrini,et al.  Multiple high-grade gliomas: epidemiology, management, and outcome. A systematic review and meta-analysis , 2019, Neurosurgical Review.

[3]  J. Nör,et al.  Expression of Cancer Stem Cell Biomarkers in Human Head and Neck Carcinomas: a Systematic Review , 2018, Stem Cell Reviews and Reports.

[4]  B. Pasche,et al.  Truncated Glioma-Associated Oncogene Homolog 1 (tGLI1) Mediates Mesenchymal Glioblastoma via Transcriptional Activation of CD44. , 2018, Cancer research.

[5]  S. Roy,et al.  Mesenchymal splice isoform of CD44 (CD44s) promotes EMT/invasion and imparts stem‐like properties to ovarian cancer cells , 2018, Journal of cellular biochemistry.

[6]  B. Kamińska,et al.  Some chemotherapeutics-treated colon cancer cells display a specific phenotype being a combination of stem-like and senescent cell features , 2018, Cancer biology & therapy.

[7]  Yu-Ting Hsu,et al.  Osteopontin–integrin engagement induces HIF-1α–TCF12-mediated endothelial-mesenchymal transition to exacerbate colorectal cancer , 2017, Oncotarget.

[8]  Alasdair J. G. Gray,et al.  The IUPHAR/BPS Guide to PHARMACOLOGY in 2018: updates and expansion to encompass the new guide to IMMUNOPHARMACOLOGY , 2017, Nucleic Acids Res..

[9]  A. Kawauchi,et al.  Anti-oncogenic activities of cyclin D1b siRNA on human bladder cancer cells via induction of apoptosis and suppression of cancer cell stemness and invasiveness. , 2017, International journal of oncology.

[10]  D. Lindgren,et al.  CD44 Interacts with HIF-2α to Modulate the Hypoxic Phenotype of Perinecrotic and Perivascular Glioma Cells. , 2017, Cell reports.

[11]  M. Aghaei,et al.  Apoptosis and cell cycle regulatory effects of adenosine by modulation of GLI‐1 and ERK1/2 pathways in CD44+ and CD24− breast cancer stem cells , 2017, Cell proliferation.

[12]  T. Krech,et al.  Gamma‐Secretase Inhibitor IX (GSI) Impairs Concomitant Activation of Notch and Wnt‐Beta‐Catenin Pathways in CD44+ Gastric Cancer Stem Cells , 2017, Stem cells translational medicine.

[13]  R. Young,et al.  Identification of a cancer stem cell-specific function for the histone deacetylases, HDAC1 and HDAC7, in breast and ovarian cancer , 2016, Oncogene.

[14]  Yukiko Matsuoka,et al.  systemsDock: a web server for network pharmacology-based prediction and analysis , 2016, Nucleic Acids Res..

[15]  S. McGuire.  World Cancer Report 2014. Geneva, Switzerland: World Health Organization, International Agency for Research on Cancer, WHO Press, 2015. , 2016, Advances in nutrition.

[16]  John C McGrath,et al.  Implementing guidelines on reporting research using animals (ARRIVE etc.): new requirements for publication in BJP , 2015, British journal of pharmacology.

[17]  O. Gallego,et al.  Nonsurgical treatment of recurrent glioblastoma. , 2015, Current oncology.

[18]  P. Herrlich,et al.  Inside-out Regulation of Ectodomain Cleavage of Cluster-of-Differentiation-44 (CD44) and of Neuregulin-1 Requires Substrate Dimerization*♦ , 2015, The Journal of Biological Chemistry.

[19]  Seok-Jun Kim,et al.  Cleaved CD44 intracellular domain supports activation of stemness factors and promotes tumorigenesis of breast cancer , 2015, Oncotarget.

[20]  A. Morokoff,et al.  Coexpression analysis of CD133 and CD44 identifies Proneural and Mesenchymal subtypes of glioblastoma multiforme , 2015, Oncotarget.

[21]  J. Huse,et al.  Osteopontin-CD44 signaling in the glioma perivascular niche enhances cancer stem cell phenotypes and promotes aggressive tumor growth. , 2014, Cell stem cell.

[22]  M. Biffoni,et al.  CD44v6 is a marker of constitutive and reprogrammed cancer stem cells driving colon cancer metastasis. , 2014, Cell stem cell.

[23]  H. Kitano,et al.  Combining Machine Learning Systems and Multiple Docking Simulation Packages to Improve Docking Prediction Reliability for Network Pharmacology , 2013, PloS one.

[24]  Joanna L. Sharman,et al.  The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands , 2013, Nucleic Acids Res..

[25]  E. Nevo,et al.  High molecular weight hyaluronan mediates the cancer resistance of the naked mole-rat , 2013, Nature.

[26]  D. Braun,et al.  Microscale thermophoresis quantifies biomolecular interactions under previously challenging conditions. , 2013, Methods.

[27]  I. Ghosh,et al.  Overexpression of Hyaluronan-binding Protein 1 (HABP1/p32/gC1qR) in HepG2 Cells Leads to Increased Hyaluronan Synthesis and Cell Proliferation by Up-regulation of Cyclin D1 in AKT-dependent Pathway* , 2012, The Journal of Biological Chemistry.

[28]  A. Fattorossi,et al.  Hyaluronic acid–paclitaxel: effects of intraperitoneal administration against CD44(+) human ovarian cancer xenografts , 2011, Cancer Chemotherapy and Pharmacology.

[29]  M. Zöller.  CD44: can a cancer-initiating cell profit from an abundantly expressed molecule? , 2011, Nature Reviews Cancer.

[30]  J. Baselga,et al.  TGF-β Receptor Inhibitors Target the CD44(high)/Id1(high) Glioma-Initiating Cell Population in Human Glioblastoma. , 2010, Cancer cell.

[31]  J. Couchman,et al.  Transmembrane signaling proteoglycans. , 2010, Annual review of cell and developmental biology.

[32]  I. Cuthill,et al.  Animal Research: Reporting In Vivo Experiments: The ARRIVE Guidelines , 2010, British journal of pharmacology.

[33]  M. Slomiany,et al.  Inhibition of Functional Hyaluronan-CD44 Interactions in CD133-positive Primary Human Ovarian Carcinoma Cells by Small Hyaluronan Oligosaccharides , 2009, Clinical Cancer Research.

[34]  R. Weinberg,et al.  Growth-Inhibitory and Tumor- Suppressive Functions of p53 Depend on Its Repression of CD44 Expression , 2008, Cell.

[35]  Wasim S Khan,et al.  Hypoxic conditions increase hypoxia-inducible transcription factor 2α and enhance chondrogenesis in stem cells from the infrapatellar fat pad of osteoarthritis patients , 2007, Arthritis research & therapy.

[36]  I. Campbell,et al.  Structures of the Cd44–hyaluronan complex provide insight into a fundamental carbohydrate-protein interaction , 2007, Nature Structural &Molecular Biology.

[37]  J. Dick,et al.  Targeting of CD44 eradicates human acute myeloid leukemic stem cells , 2006, Nature Medicine.

[38]  Thomas D. Wu,et al.  Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis. , 2006, Cancer cell.

[39]  S. Hibino,et al.  Laminin alpha5 chain metastasis- and angiogenesis-inhibiting peptide blocks fibroblast growth factor 2 activity by binding to the heparan sulfate chains of CD44. , 2005, Cancer research.

[40]  H. Saya,et al.  Mechanism and biological significance of CD44 cleavage , 2004, Cancer science.

[41]  N. Hollander,et al.  Anti-Idiotype × Anti-CD44 Bispecific Antibodies Inhibit Invasion of Lymphoid Organs by B Cell Lymphoma1 , 2004, The Journal of Immunology.

[42]  Cynthia Hawkins,et al.  Identification of a cancer stem cell in human brain tumors. , 2003, Cancer research.

[43]  B. Stewart,et al.  World Cancer Report , 2003 .

[44]  F. Speleman,et al.  Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes , 2002, Genome Biology.

[45]  L. Bourguignon,et al.  CD44 Interaction with c-Src Kinase Promotes Cortactin-mediated Cytoskeleton Function and Hyaluronic Acid-dependent Ovarian Tumor Cell Migration* , 2001, The Journal of Biological Chemistry.

[46]  M. Sy,et al.  Phorbol myristate acetate stimulates the dimerization of CD44 involving a cysteine in the transmembrane domain. , 1997, Journal of immunology.

[47]  I. Stamenkovic,et al.  CD44 isoforms containing exon V3 are responsible for the presentation of heparin-binding growth factor , 1995, The Journal of cell biology.

[48]  Y. Okada,et al.  Isolation of Cancer Stem Cells by Side Population Method. , 2018, Methods in molecular biology.

[49]  E. Nevo,et al.  High-molecular-mass hyaluronan mediates the cancer resistance of the naked mole rat , 2013 .

[50]  A. Pietras.  Cancer stem cells in tumor heterogeneity. , 2011, Advances in cancer research.

[51]  R. Voort,et al.  Hepatocyte growth factor, Met, and CD44. Amenage a trois in B cells , 2000 .

[52]  R. Brumback.  Neurology and Clinical Neuroscience , 1993, Oklahoma Notes.

[53]  Microscale Thermophoresis , 2022 .